Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 11Prostatic Neoplasms 9Uterine Neoplasms 2Hyperthermia 2Endometrial Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Rhabdomyosarcoma 1Recurrence 1Ovarian Neoplasms 1Neoplasms 1Lung Neoplasms 1Locally Advanced Cervical Adenocarcinoma 1Head and Neck Neoplasms 1Genital Neoplasms, Female 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Endometrial Clear Cell Adenocarcinoma 1Directly Observed Therapy 1Cervical Adenocarcinoma 1Carcinoma, Renal Cell 1Adenocarcinoma 1

Interventions

Surgical Procedures, Operative 1Drug Therapy 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Directly Observed Therapy × Brachytherapy × Clear all
NCT06350825 2024-04-05

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting
200 enrolled
Genitourinary

Prostatic Neoplasms, Directly Observed Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡